Quest Diagnostics To Acquire Shiel Medical Laboratory Business From Fresenius

(RTTNews) - Quest Diagnostics (DGX) announced an agreement under which Quest will acquire the Shiel Medical Laboratory business from Fresenius Medical Care. Shiel is a clinical laboratory provider serving the New York-New Jersey metropolitan area. The acquisition is expected to result in an expanded network of Quest patient service centers in the region.

Quest Diagnostics and Fresenius Medical Care will also collaborate on identifying patients with early-stage chronic kidney disease, based on Quest's laboratory data analytics. Fresenius Medical Care's dialysis-related laboratory services business, Spectra Labs, is not affected by the divestiture.